Spots Global Cancer Trial Database for Prevalence of HbA1C in Women With PCOS

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Prevalence of HbA1C in Women With PCOS

Official Title: Prevalence of HbA1C in Different Categories of Obesity in Women With PCOS'A Propective Randomized Control Study

Study ID: NCT01838122

Conditions

Polycystic Ovarian Syndrome

Pelvic Endometriosis

Insulin Resistance

Non-insulin Dependent Diabetes Mellitus

Tubal Obstruction

Interventions

Study Description

Brief Summary: Women with PCOS have been observed to be potential diabetics.Recently,American Diabetes Association has suggested screening of women with PCOS for HbA1C.

Detailed Description: In view of recent suggestion of American Diabetes Association(ADA)to screen women with PCOS for HbA1C,we intend to study its prevalence in all categories of obesity in women with PCOS. Women with PCOS by Rotterdam criteria will be screened for insulin resistance by using different techniques or tests. Further, the sensitivity and specificity of HbA1C will be compared with sensitivity and specificity of other insulin resistance markers such as OGTT, Free androgen index, free testosterone, fasting insulin to glucose ratio, HOMA-IR and HOMA-B-CELL.